OSR Holdings, Inc. Logo

OSR Holdings, Inc.

Acquires biopharma R&D platforms to build a diverse portfolio of healthcare therapies.

OSRH | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
10900 NE 4TH STREET, SUITE 2300, 98004 BELLEVUE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OSR Holdings, Inc. is a global healthcare holding company that operates on a hub-and-spoke model. The company's strategy involves acquiring or partnering with biopharmaceutical firms that possess innovative, proprietary R&D platforms rather than single assets. Through this approach, OSR Holdings builds a diverse portfolio of therapies and healthcare solutions, including the development of oral immunotherapies for cancer treatment. The company's stated mission is to accelerate healthcare innovation to improve health and wellness outcomes worldwide and enhance the quality of life for patients and their families.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OSR Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OSR Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OSR Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cartesian Therapeutics, Inc. Logo
Pioneering mRNA-engineered cell therapies to treat autoimmune diseases.
United States of America
RNAC
CASI Pharmaceuticals, Inc. Logo
Develops and commercializes drugs for oncology, transplant, and autoimmune disease.
United States of America
CASI
CASSAVA SCIENCES INC Logo
Clinical-stage biotech developing oral drug simufilam for CNS disorders like TSC-related epilepsy.
United States of America
SAVA
CATALYST PHARMACEUTICALS, INC. Logo
Advancing therapies for rare neuromuscular and neurological diseases like LEMS.
United States of America
CPRX
cbdMD, Inc. Logo
Produces & distributes lab-tested CBD wellness products for people and pets.
United States of America
YCBD
CDT Equity Inc. Logo
Clinical-stage biopharma using AI to enhance and advance therapies for unmet medical needs.
United States of America
CDT
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom
CEL
Celcuity Inc. Logo
Developing targeted PI3K/mTOR inhibitor therapies for breast and prostate solid tumors.
United States of America
CELC
Celemics, Inc. Logo
Develops custom NGS panels and bioinformatics for research and clinical diagnostics.
South Korea
331920
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
South Korea
308430

Talk to a Data Expert

Have a question? We'll get back to you promptly.